Intralymphatic Injection of Autoantigen in Type 1 Diabetes

N Engl J Med. 2017 Feb 16;376(7):697-699. doi: 10.1056/NEJMc1616343.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Area Under Curve
  • Autoantigens / administration & dosage*
  • Autoantigens / adverse effects
  • C-Peptide / blood
  • Diabetes Mellitus, Type 1 / drug therapy*
  • Drug Therapy, Combination
  • Glutamate Decarboxylase / administration & dosage*
  • Glutamate Decarboxylase / adverse effects
  • Historically Controlled Study
  • Humans
  • Injections, Intralymphatic / adverse effects
  • Pilot Projects
  • Vitamin D / therapeutic use
  • Vitamins / therapeutic use
  • Young Adult

Substances

  • Autoantigens
  • C-Peptide
  • Vitamins
  • Vitamin D
  • Glutamate Decarboxylase